In the next video I’ll report on another study showing the effectiveness of stem cells in the treatment of osteoarthritis…
New Study Shows Positive Results with Bone Marrow Concentrate (BMC) Injection for Knee Osteoarthritis
Bone Marrow Concentrate (BMC) has evolved in recent years as a one of the most promising therapies for Osteoarthritis (OA). The anti inflammatory and regenerative properties of BMC have been shown in early studies to relieve pain and stiffness, as well as improve joint function, in patients suffering from degenerative arthritis.
A recent study, reported by Julie Patchis, published in the European Journal of Surgery and Traumatology evaluated 41 patients (75 knees) with a mean age of 60.7 years old, diagnosed with degenerative arthritis, who underwent intra articular injection of BMC with adipose tissue. Each patient was assigned a radiologic arthritis score (I-IV) via the Kellgren-Lawrence grading scale, and Pre/Post operative Visual Analogue Score (VAS) and functional scores were used for evaluation at 3, 6, and 12 months.
The study revealed a decrease in the mean VAS from 7.0 preoperatively to 4.1, 3.5, and 3.3 at the 3, 6, and 12 months follow up appointments. Functional improvements were also illustrated via the International Knee Documentation Committee score, SF-36 score, Knee and Osteoarthitis Outcome score, and the Lysholm Knee Questionnaire.
The results contribute to the growing research trends supporting the treatment of OA with intra articular injections of BMC. However, less impressive improvements were seen in Grade IV arthritis patients and this suggests BMC to be more effective in early to moderate phases of degenerative arthritis. Although, further studies are needed to more thoroughly evaluate the efficacy of BMC therapy, this study adds further support to the regenerative potential of bone marrow for degenerative joint diseases such as arthritis.